INVESTOR NEWS

Nov 11, 2019

Notice of extraordinary general meeting 21.11.2019

An extraordinary general meeting of Gentian Diagnostics AS, reg. no 983 860 516 (the "Company"), will be held..

Nov 07, 2019

Third quarter financial report

Moss, 7 November 2019

Oct 24, 2019

Board resignation

Moss, 24 October 2019

Aug 15, 2019

2nd quarter and first half 2019 report

Aug 14, 2019

2nd quarter and first half 2018 report

Moss 14.08.19

Aug 13, 2019

Gentian becomes sole reagent supplier in sales channel agreement between Roche and BÜHLMANN for fCAL® turbo

Moss, 13.08.2019

Jul 03, 2019

Beckman Coulter and Gentian extend their cooperation in the expanding business in the field of renal testing

Moss, 03.07.2019

Jun 28, 2019

fCAL® turbo RECEIVES 510(K) CLEARANCE IN THE USA

Moss, 28.06.2019

May 28, 2019

MINUTES OF ANNUAL GENERAL MEETING 2019

Minutes of Annual General Meeting

May 27, 2019

Gentian hosted a successful workshop for Calprotectin at EuroMedLab 2019 in Barcelona

Moss, 24.05.2019